Vanessa Moore

ORCID: 0000-0001-6869-9012
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cystic Fibrosis Research Advances
  • Hemodynamic Monitoring and Therapy
  • Central Venous Catheters and Hemodialysis
  • Mycobacterium research and diagnosis
  • Health Systems, Economic Evaluations, Quality of Life
  • Nosocomial Infections in ICU
  • Infection Control in Healthcare
  • Food Security and Health in Diverse Populations
  • Geriatric Care and Nursing Homes
  • Cardiac pacing and defibrillation studies
  • Neonatal Respiratory Health Research
  • Sepsis Diagnosis and Treatment
  • Respiratory Support and Mechanisms
  • Respiratory viral infections research
  • Cardiac Structural Anomalies and Repair
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Cardiac Valve Diseases and Treatments
  • Hormonal and reproductive studies
  • Tuberculosis Research and Epidemiology
  • Pneumonia and Respiratory Infections
  • Infectious Diseases and Mycology
  • Sexual Differentiation and Disorders
  • Long-Term Effects of COVID-19
  • Prostate Cancer Treatment and Research

Paracelsus Medical University
2024-2025

Prince Charles Hospital
2010-2024

Duke Medical Center
2016

Clinical Research Institute
2016

Overton Brooks VA Medical Center
2006

The survival benefit of a strategy coronary-artery bypass grafting (CABG) added to guideline-directed medical therapy, as compared with therapy alone, in patients coronary artery disease, heart failure, and severe left ventricular systolic dysfunction remains unclear.

10.1056/nejmoa1602001 article EN New England Journal of Medicine 2016-04-03

Elexacaftor/tezacaftor/ivacaftor (ETI) is a CFTR modulator therapy that has dramatically improved the health outcomes for many people with cystic fibrosis (pwCF). There increasing interest in role of modulators prevention and treatment respiratory infections pwCF. A male patient F508del homozygous developed cavitary Mycobacteroides abscessus subspecies bolletii & massiliense infection. Antimycobacterial was not given as, discussion patient's family, it deemed unlikely intensive regimen would...

10.1016/j.jcf.2024.05.008 article EN cc-by Journal of Cystic Fibrosis 2024-05-21

Background: Healthcare systems worldwide are increasingly burdened by rising costs, growing patient demand, and limited resources. In this context, cost-effectiveness analysis (CEA) plays a vital role in evaluating the clinical value of medical interventions relative to their costs. Despite lack evidence supporting necessity, routine post-removal chest X-rays for central venous catheters (CVCs) still performed some hospitals due persistent misconceptions about benefits. This study seeks...

10.3390/jcm14041397 article EN Journal of Clinical Medicine 2025-02-19

Pandemic Influenza A (H1N1) 2009 is a novel viral infection that emerged in March 2009. This the first report addressing clinical course of patients with cystic fibrosis (CF) and H1N1 infection.All an influenza-like illness (ILI) attending our adult centre during July were identified. Baseline respiratory function, nutritional status, approach to management short-term recorded.Most experienced mild able be managed antiviral agents as outpatient. Robust control policies implemented limit...

10.1186/1471-2466-10-8 article EN cc-by BMC Pulmonary Medicine 2010-02-25

Background/Objectives: The study outlines the systematic approach taken to develop and apply a robust NLP algorithm determine necessity of performing routine imaging after central venous catheter (CVC) placement removal, based on incidence pneumothorax observed. Methods: Electronic health records from four university hospitals in Salzburg, Austria, X-rays performed between 2012 2021 following CVC procedures, were analyzed using an al-gorithm. detected radiologists' reports clinician...

10.20944/preprints202410.0740.v1 preprint EN 2024-10-10

The 2013 update of the Infection Prevention and Control (IP&C) Guideline outlined recommendations to prevent spread CF respiratory pathogens. We aimed investigate current infection control practices used in Australian New Zealand (NZ) centers.Two online surveys were distributed NZ centers regarding uptake selected IP&C recommendations. One survey was all Medical Directors Lead Nurses second Physiotherapists.The response rate 60% (60/100) for medical/nursing 58% (14/24) physiotherapy. Over...

10.1186/s12890-020-1052-y article EN cc-by BMC Pulmonary Medicine 2020-01-17

Background: Cystic fibrosis (CF) is a multisystem disorder caused by mutations in the cystic transmembrane conductance regulator (CFTR) gene. We describe distribution of CFTR mutation profiles sub-tropical Queensland, Australia, and characterise phenotypes associated with ‘rare’ combinations. Methods: conducted retrospective observational study to analyse 322 people CF (pwCF) under care large adult centre Australia. Molecular pathology results were available for all identifiable mutations....

10.3390/jcm13206210 article EN Journal of Clinical Medicine 2024-10-18

Background: This study presents a systematic approach using natural language processing (NLP) algorithm to assess the necessity of routine imaging after central venous catheter (CVC) placement and removal. With pneumothorax being key complication CVC procedures, this research aims provide evidence-based recommendations for optimizing protocols minimizing unnecessary risks. Methods: We analyzed electronic health records from four university hospitals in Salzburg, Austria, focusing on X-rays...

10.3390/diagnostics14242792 article EN cc-by Diagnostics 2024-12-12

10.1097/00004630-200103002-00213 article EN Journal of Burn Care & Rehabilitation 2001-03-01
Coming Soon ...